Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Glossmann

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|September 14, 2000
["Lean management" in hospitals: potentials and limitations]J P Glossmann, O Schliebusch, V Diehl, et al.
Studies in Health Technology and Informatics|February 24, 2001
Can factors influencing in-patient treatment in Hodgkin's disease be identified?--Retrospective analysis of HD6 patients of the GHSGB Pfistner, U Paulus, J P Glossmann, et al.
Annals of Hematology|August 12, 2003
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trialJ-P Glossmann, A Engert, G Wassmer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Economic burden of clinical trials in lung cancer in a German Comprehensive Cancer CenterF Kron, A Kostenko, M Scheffler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II studyA Josting, M Sieniawski, J-P Glossmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)A Josting, C Rudolph, M Mapara, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Medizinische Klinik (Munich, Germany : 1983)|September 14, 2000
["Lean management" in hospitals: potentials and limitations]J P Glossmann, O Schliebusch, V Diehl, et al.
Studies in Health Technology and Informatics|February 24, 2001
Can factors influencing in-patient treatment in Hodgkin's disease be identified?--Retrospective analysis of HD6 patients of the GHSGB Pfistner, U Paulus, J P Glossmann, et al.
Annals of Hematology|August 12, 2003
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trialJ-P Glossmann, A Engert, G Wassmer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Economic burden of clinical trials in lung cancer in a German Comprehensive Cancer CenterF Kron, A Kostenko, M Scheffler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II studyA Josting, M Sieniawski, J-P Glossmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG)A Josting, C Rudolph, M Mapara, et al.
Pageof 1